Free Trial

Deutsche Bank AG Has $5.38 Million Stake in Exponent, Inc. $EXPO

Exponent logo with Business Services background

Key Points

  • Deutsche Bank AG has reduced its stake in Exponent, Inc. by 5.8%, owning 66,371 shares worth approximately $5.38 million following the sale of 4,120 shares in the 1st quarter.
  • Exponent reported a quarterly EPS of $0.52, exceeding analysts' expectations, with revenue of $132.87 million, up 7.3% year-over-year.
  • The company announced a quarterly dividend of $0.30 per share, representing a 1.7% yield, with the ex-dividend date set for September 5th.
  • Need better tools to track Exponent? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Deutsche Bank AG decreased its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 5.8% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 66,371 shares of the business services provider's stock after selling 4,120 shares during the period. Deutsche Bank AG owned about 0.13% of Exponent worth $5,380,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Ontario Teachers Pension Plan Board grew its position in Exponent by 1.2% during the 1st quarter. Ontario Teachers Pension Plan Board now owns 31,096 shares of the business services provider's stock worth $2,521,000 after purchasing an additional 369 shares in the last quarter. Geneva Capital Management LLC raised its position in Exponent by 11.2% during the first quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider's stock valued at $141,517,000 after buying an additional 176,152 shares during the period. Argent Trust Co acquired a new position in Exponent during the first quarter valued at $201,000. Malaga Cove Capital LLC raised its position in Exponent by 40.9% during the first quarter. Malaga Cove Capital LLC now owns 7,505 shares of the business services provider's stock valued at $608,000 after buying an additional 2,178 shares during the period. Finally, Jefferies Financial Group Inc. acquired a new position in Exponent during the first quarter valued at $1,071,000. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, VP John Pye sold 2,000 shares of Exponent stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $76.32, for a total value of $152,640.00. Following the transaction, the vice president owned 29,204 shares in the company, valued at $2,228,849.28. This trade represents a 6.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Catherine Corrigan sold 4,896 shares of Exponent stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $71.09, for a total transaction of $348,056.64. Following the completion of the transaction, the chief executive officer owned 81,342 shares in the company, valued at $5,782,602.78. This trade represents a 5.68% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 10,064 shares of company stock worth $735,621. Insiders own 1.60% of the company's stock.

Exponent Stock Performance

NASDAQ:EXPO traded up $0.3050 during trading hours on Wednesday, hitting $69.9050. 194,831 shares of the company's stock traded hands, compared to its average volume of 317,271. The firm has a market cap of $3.53 billion, a P/E ratio of 34.95 and a beta of 0.89. Exponent, Inc. has a twelve month low of $63.81 and a twelve month high of $115.75. The stock's fifty day moving average price is $73.13 and its two-hundred day moving average price is $78.41.

Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The company had revenue of $132.87 million during the quarter, compared to the consensus estimate of $130.82 million. During the same quarter in the prior year, the firm earned $0.57 EPS. The company's revenue was up 7.3% compared to the same quarter last year. On average, equities research analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.7%. The ex-dividend date is Friday, September 5th. Exponent's dividend payout ratio (DPR) is 60.00%.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten
Palantir’s Soaring Valuation—Justified or Overhyped?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines